Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Clinical trial NCT00197249 · COMPLETED
Trial details
- NCT number
- NCT00197249
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2003-06-01
- Enrollment
- 1034
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.